BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van der Koog L, Gandek TB, Nagelkerke A. Liposomes and Extracellular Vesicles as Drug Delivery Systems: A Comparison of Composition, Pharmacokinetics, and Functionalization. Adv Healthc Mater 2022;11:e2100639. [PMID: 34165909 DOI: 10.1002/adhm.202100639] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 28.0] [Reference Citation Analysis]
Number Citing Articles
1 Papagiannopoulos A, Sklapani A, Len A, Radulescu A, Pavlova E, Slouf M. Protein-induced transformation of unilamellar to multilamellar vesicles triggered by a polysaccharide. Carbohydr Polym 2023;303:120478. [PMID: 36657851 DOI: 10.1016/j.carbpol.2022.120478] [Reference Citation Analysis]
2 Liu F, Sun T, An Y, Ming L, Li Y, Zhou Z, Shang F. The potential therapeutic role of extracellular vesicles in critical-size bone defects: Spring of cell-free regenerative medicine is coming. Front Bioeng Biotechnol 2023;11. [DOI: 10.3389/fbioe.2023.1050916] [Reference Citation Analysis]
3 Placci M, Giannotti MI, Muro S. Polymer-Based Drug Delivery Systems Under Investigation For Enzyme Replacement And Other Therapies Of Lysosomal Storage Disorders. Adv Drug Deliv Rev 2023;:114683. [PMID: 36657645 DOI: 10.1016/j.addr.2022.114683] [Reference Citation Analysis]
4 Romero-García N, Huete-Acevedo J, Mas-Bargues C, Sanz-Ros J, Dromant M, Borrás C. The Double-Edged Role of Extracellular Vesicles in the Hallmarks of Aging. Biomolecules 2023;13. [PMID: 36671550 DOI: 10.3390/biom13010165] [Reference Citation Analysis]
5 Romero-García N, Mas-Bargues C, Huete-Acevedo J, Borrás C. Extracellular Vesicles and Cellular Ageing. Subcell Biochem 2023;102:271-311. [PMID: 36600137 DOI: 10.1007/978-3-031-21410-3_11] [Reference Citation Analysis]
6 Park H, Sut TN, Yoon BK, Zhdanov VP, Cho NJ, Jackman JA. Unraveling How Cholesterol Affects Multivalency-Induced Membrane Deformation of Sub-100 nm Lipid Vesicles. Langmuir 2022;38:15950-9. [PMID: 36515977 DOI: 10.1021/acs.langmuir.2c02252] [Reference Citation Analysis]
7 Sanders OD. Virus-Like Cytosolic and Cell-Free Oxidatively Damaged Nucleic Acids Likely Drive Inflammation, Synapse Degeneration, and Neuron Death in Alzheimer’s Disease. ADR 2022. [DOI: 10.3233/adr-220047] [Reference Citation Analysis]
8 Syed MH, Zahari MAKM, Khan MMR, Beg MDH, Abdullah N. An overview on recent biomedical applications of biopolymers: Their role in drug delivery systems and comparison of major systems. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.104121] [Reference Citation Analysis]
9 Han Y, Zhu Y, Youngblood HA, Almuntashiri S, Jones TW, Wang X, Liu Y, Somanath PR, Zhang D. Nebulization of extracellular vesicles: A promising small RNA delivery approach for lung diseases. J Control Release 2022;352:556-69. [PMID: 36341934 DOI: 10.1016/j.jconrel.2022.10.052] [Reference Citation Analysis]
10 Kheoane PS, Enslin GM, Tarirai C. Formulation and characterization of liposomes containing drug absorption enhancers for optimized anti-HIV and antimalarial drug delivery. Drug Deliv and Transl Res 2022. [DOI: 10.1007/s13346-022-01264-w] [Reference Citation Analysis]
11 Zhang J, Brown A, Johnson B, Diebold D, Asano K, Marriott G, Lu B. Genetically Engineered Extracellular Vesicles Harboring Transmembrane Scaffolds Exhibit Differences in Their Size, Expression Levels of Specific Surface Markers and Cell-Uptake. Pharmaceutics 2022;14. [PMID: 36559058 DOI: 10.3390/pharmaceutics14122564] [Reference Citation Analysis]
12 Gholikhani T, Kumar S, Valizadeh H, Mahdinloo S, Adibkia K, Zakeri-Milani P, Barzegar-Jalali M, Jimenez B. Advances in Aptamers-Based Applications in Breast Cancer: Drug Delivery, Therapeutics, and Diagnostics. Int J Mol Sci 2022;23. [PMID: 36430951 DOI: 10.3390/ijms232214475] [Reference Citation Analysis]
13 Quinn SD, Dresser L, Graham S, Conteduca D, Shepherd J, Leake MC. Crowding-induced morphological changes in synthetic lipid vesicles determined using smFRET. Front Bioeng Biotechnol 2022;10. [DOI: 10.3389/fbioe.2022.958026] [Reference Citation Analysis]
14 Chaffey L, Roberti A, Greaves DR. Drug repurposing in cardiovascular inflammation: Successes, failures, and future opportunities. Front Pharmacol 2022;13:1046406. [DOI: 10.3389/fphar.2022.1046406] [Reference Citation Analysis]
15 Ghasemi S, Ahmadi L, Farjadian F. Thermo-responsive PNIPAAm-b-PLA amphiphilic block copolymer micelle as nanoplatform for docetaxel drug release. J Mater Sci. [DOI: 10.1007/s10853-022-07711-w] [Reference Citation Analysis]
16 Ashrafizadeh M, Hushmandi K, Mirzaei S, Bokaie S, Bigham A, Makvandi P, Rabiee N, Thakur VK, Kumar AP, Sharifi E, Varma RS, Aref AR, Wojnilowicz M, Zarrabi A, Karimi-Maleh H, Voelcker NH, Mostafavi E, Orive G. Chitosan-based nanoscale systems for doxorubicin delivery: Exploring biomedical application in cancer therapy. Bioeng Transl Med 2023;8:e10325. [PMID: 36684100 DOI: 10.1002/btm2.10325] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 M. Alfagih I. Liposomes for Targeting RNA Interference-Based Therapy in Inflammatory Bowel Diseases. Liposomes - Recent Advances, New Perspectives and Applications [Working Title] 2022. [DOI: 10.5772/intechopen.106829] [Reference Citation Analysis]
18 Fang Z, Liu K. Plant-derived extracellular vesicles as oral drug delivery carriers. J Control Release 2022;350:389-400. [PMID: 36037973 DOI: 10.1016/j.jconrel.2022.08.046] [Reference Citation Analysis]
19 Liu A, Yang G, Liu Y, Liu T. Research progress in membrane fusion-based hybrid exosomes for drug delivery systems. Front Bioeng Biotechnol 2022;10:939441. [DOI: 10.3389/fbioe.2022.939441] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Mo L, Zhang F, Chen F, Xia L, Huang Y, Mo Y, Zhang L, Huang D, He S, Deng J, Hao E, Du Z. Progress on structural modification of Tetrandrine with wide range of pharmacological activities. Front Pharmacol 2022;13:978600. [DOI: 10.3389/fphar.2022.978600] [Reference Citation Analysis]
21 Pham DT, Nguyen LP, Pham QTH, Pham CK, Pham DTN, Viet NT, Nguyen HVT, Tran TQ, Nguyen DT. A low-cost, flexible extruder for liposomes synthesis and application for Murrayafoline A delivery for cancer treatment. J Biomater Appl 2022;:8853282221112491. [PMID: 35786069 DOI: 10.1177/08853282221112491] [Reference Citation Analysis]
22 Kim MA, Lee CM. NIR-Mediated drug release and tumor theranostics using melanin-loaded liposomes. Biomater Res 2022;26:22. [PMID: 35659113 DOI: 10.1186/s40824-022-00270-w] [Reference Citation Analysis]
23 Sanmartin MC, Borzone FR, Giorello MB, Yannarelli G, Chasseing NA. Mesenchymal Stromal Cell-Derived Extracellular Vesicles as Biological Carriers for Drug Delivery in Cancer Therapy. Front Bioeng Biotechnol 2022;10:882545. [DOI: 10.3389/fbioe.2022.882545] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Taléns-Visconti R, Díez-Sales O, de Julián-Ortiz JV, Nácher A. Nanoliposomes in Cancer Therapy: Marketed Products and Current Clinical Trials. Int J Mol Sci 2022;23:4249. [PMID: 35457065 DOI: 10.3390/ijms23084249] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
25 Cao Y, Dong X, Chen X. Polymer-Modified Liposomes for Drug Delivery: From Fundamentals to Applications. Pharmaceutics 2022;14:778. [DOI: 10.3390/pharmaceutics14040778] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
26 N’diaye E, Orefice NS, Ghezzi C, Boumendjel A. Chemically Modified Extracellular Vesicles and Applications in Radiolabeling and Drug Delivery. Pharmaceutics 2022;14:653. [DOI: 10.3390/pharmaceutics14030653] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
27 Amiri A, Bagherifar R, Ansari Dezfouli E, Kiaie SH, Jafari R, Ramezani R. Exosomes as bio-inspired nanocarriers for RNA delivery: preparation and applications. J Transl Med 2022;20. [DOI: 10.1186/s12967-022-03325-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
28 Xing Z, Zhao C, Wu S, Yang D, Zhang C, Wei X, Wei X, Su H, Liu H, Fan Y. Hydrogel Loaded with VEGF/TFEB-Engineered Extracellular Vesicles for Rescuing Critical Limb Ischemia by a Dual-Pathway Activation Strategy. Adv Healthc Mater 2022;11:e2100334. [PMID: 34297471 DOI: 10.1002/adhm.202100334] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
29 Pramanik S, Steinkühler J, Dimova R, Spatz J, Lipowsky R. Binding of His-tagged fluorophores to lipid bilayers of giant vesicles†.. [DOI: 10.1101/2022.02.01.478643] [Reference Citation Analysis]
30 Gelibter S, Marostica G, Mandelli A, Siciliani S, Podini P, Finardi A, Furlan R. The impact of storage on extracellular vesicles: A systematic study. J Extracell Vesicles 2022;11:e12162. [PMID: 35102719 DOI: 10.1002/jev2.12162] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 13.0] [Reference Citation Analysis]
31 Rodríguez DA, Vader P. Extracellular Vesicle-Based Hybrid Systems for Advanced Drug Delivery. Pharmaceutics 2022;14:267. [DOI: 10.3390/pharmaceutics14020267] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 Furlani F, Rossi A, Grimaudo MA, Bassi G, Giusto E, Molinari F, Lista F, Montesi M, Panseri S. Controlled Liposome Delivery from Chitosan-Based Thermosensitive Hydrogel for Regenerative Medicine. Int J Mol Sci 2022;23:894. [PMID: 35055097 DOI: 10.3390/ijms23020894] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
33 Lee J, Lee J, Chakraborty K, Hwang J, Lee Y. Exosome-based drug delivery systems and their therapeutic applications. RSC Adv 2022;12:18475-92. [DOI: 10.1039/d2ra02351b] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Zhyvolozhnyi AY, Horak IR, Skaterna TD, Khudiakova OV, Vainio SJ, Samoylenko AA, Drobot LB. Composition of EVs markers under normoxic and hypoxic conditions depends on the expression level of adaptor protein Ruk/CIN85 in mouse renal carcinoma Renca cells. Biopolym Cell 2021;37:325-334. [DOI: 10.7124/bc.000a5e] [Reference Citation Analysis]
35 Wang WJ, Kan CD, Chen CY, Meng YY, Wang JN, Chen WL, Chen CH, Li WP. Synthetic Poly(lactic-co-glycolic Acid) Microvesicles as a Feasible Carbon Monoxide-Releasing Platform for Cancer Treatment. Membranes (Basel) 2021;11:818. [PMID: 34832047 DOI: 10.3390/membranes11110818] [Reference Citation Analysis]
36 Kannappan V, Ali M, Small B, Rajendran G, Elzhenni S, Taj H, Wang W, Dou QP. Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents. Front Mol Biosci 2021;8:741316. [PMID: 34604310 DOI: 10.3389/fmolb.2021.741316] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
37 Kang M, Lee CS, Lee M. Bioactive Scaffolds Integrated with Liposomal or Extracellular Vesicles for Bone Regeneration. Bioengineering (Basel) 2021;8:137. [PMID: 34677210 DOI: 10.3390/bioengineering8100137] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]